Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

545 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Nauck M, et al. Diabetologia. 1986 Jan;29(1):46-52. doi: 10.1007/BF02427280. Diabetologia. 1986. PMID: 3514343
The [pre-] history of the incretin concept.
Creutzfeldt W. Creutzfeldt W. Regul Pept. 2005 Jun 15;128(2):87-91. doi: 10.1016/j.regpep.2004.08.004. Regul Pept. 2005. PMID: 15780427
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Nauck MA, et al. Diabetologia. 1993 Aug;36(8):741-4. doi: 10.1007/BF00401145. Diabetologia. 1993. PMID: 8405741 Clinical Trial.
In vivo metabolic action of insulin-like growth factor I in adult rats.
Schmitz F, Hartmann H, Stümpel F, Creutzfeldt W. Schmitz F, et al. Diabetologia. 1991 Mar;34(3):144-9. doi: 10.1007/BF00418267. Diabetologia. 1991. PMID: 1884885
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. J Clin Endocrinol Metab. 1993 Apr;76(4):912-7. doi: 10.1210/jcem.76.4.8473405. J Clin Endocrinol Metab. 1993. PMID: 8473405 Clinical Trial.
Entero-insular axis and diabetes mellitus.
Creutzfeldt W. Creutzfeldt W. Horm Metab Res Suppl. 1992;26:13-8. Horm Metab Res Suppl. 1992. PMID: 1490680 Review.
Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F, Nauck MA, Ebert R, Cantor P, Hoffmann G, Choudhury AR, Schmidt WE, Creutzfeldt W. Baum F, et al. Digestion. 1992;53(3-4):189-99. doi: 10.1159/000200994. Digestion. 1992. PMID: 1291406
Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.
Nauck MA, Büsing M, Orskov C, Siegel EG, Talartschik J, Baartz A, Baartz T, Hopt UT, Becker HD, Creutzfeldt W. Nauck MA, et al. Acta Diabetol. 1993;30(1):39-45. doi: 10.1007/BF00572873. Acta Diabetol. 1993. PMID: 8329730
545 results
Jump to page
Feedback